Charles River Laboratories International, Inc (CRL) insider trading

Every open-market stock purchase and sale by Charles River Laboratories International, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • James C Foster (Director) and 5 others sold $25.7M in the last 90 days.
  • Last insider buy: Joseph W LaPlume (VP), $4.4K, 7 months ago.

Last 12 months: insiders bought $4.4K (1 buy) and sold $42.6M (10 sales). Last close $296.41 on Aug 27, 2026.

Recent CRL insider trades

DateInsiderTradeValue
Aug 25, 2026James C Foster (Director)Sold$10.1M
Aug 25, 2026James C Foster (Director)Bought (not open market)—
Aug 25, 2026James C Foster (Director)Bought (not open market)—
Aug 19, 2026Shannon M Parisotto (Officer)Sold$600K
Aug 19, 2026Birgit Girshick (CEO)Sold (not open market)—
Aug 19, 2026Shannon M Parisotto (Officer)Bought (not open market)—
Aug 18, 2026Nancy C Andrews (Director)Sold$163K
Aug 18, 2026Nancy C Andrews (Director)Bought (not open market)—
Aug 11, 2026Birgit Girshick (CEO)Sold$1.8M
Aug 11, 2026Shannon M Parisotto (Officer)Sold$1M
Aug 11, 2026Birgit Girshick (CEO)Bought (not open market)—
Aug 11, 2026Shannon M Parisotto (Officer)Bought (not open market)—
Aug 10, 2026James C Foster (Director)Sold$7.9M
Aug 10, 2026Joseph W LaPlume (VP)Sold (not open market)—
Aug 10, 2026James C Foster (Director)Bought (not open market)—
Aug 6, 2026Victoria L Creamer (C-suite exec)Sold$1.1M
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$330K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$312K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$235K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$212K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$190K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$164K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$128K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$104K
Aug 6, 2026Michael Gunnar Knell (C-suite exec)Sold$55.9K

Who's trading CRL

Get free alerts when an insider at Charles River Laboratories International, Inc files a new trade →